PubMed COVID-19 Clinical Care
34801 - 34810 of 57753 results found
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
Description
It is reported that pulmonary fibrosis has become one of the major long-term complications of COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global medical community, there are no treatments for COVID-induced
Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
Description
Coronavirus disease (COVID-19) often causes persistent symptoms long after infection, referred to as "long COVID" or post-acute COVID-19 syndrome (PACS). This phenomenon has been studied primarily concerning B-cell immunity, while the involvement of
Pediatrics in Disasters: Evolution of a Hybrid Global Health Training Program During the COVID-19 Pandemic
Description
This report describes the Pediatrics in Disasters (PEDS) course during a novel hybrid in-person and virtual format due to the coronavirus disease 2019 pandemic. International and local faculty collaborated on 2021 precourse revisions and course
A multi-methods randomized trial found that plain language versions improved parents' understanding of health recommendations
Description
CONCLUSION: Compared to SLVs, parents preferred PLRs and better understood the recommendation. Guideline developers should strive to use plain language to increase understanding, uptake, and implementation of evidence by the public.
Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion
Description
CONCLUSIONS: Kae prevents SARS-CoV-2 infection by blocking membrane fusion and possesses a broad-spectrum anti-fusion ability. These findings provide valuable insights into potential benefits of Kae-containing botanical products as a complementary
